Skip to content
10-K

Annual Report

Bionano Genomics, Inc. BNGO

0001411690-26-000007

← back to feed
Filed
Mar 23, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 19, 2026 11.09M sh
Shares Diluted FY 2025 · Dec 31, 2025 5.45M sh
Shares Diluted FY 2025 · Dec 31, 2024 1.27M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$16.35M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$68.92M
Cash And Equivalents FY 2025 · Dec 31, 2025 $2.99M
Cash And Equivalents FY 2025 · Dec 31, 2024 $9.17M
Stockholders Equity FY 2025 · Dec 31, 2025 $44.42M
Stockholders Equity FY 2025 · Dec 31, 2024 $35.38M
Stockholders Equity FY 2025 · Dec 31, 2023 $96.16M
Current Liabilities FY 2025 · Dec 31, 2025 $22.94M
Current Liabilities FY 2025 · Dec 31, 2024 $37.34M
Total Liabilities FY 2025 · Dec 31, 2025 $29.16M
Total Liabilities FY 2025 · Dec 31, 2024 $41.3M
Current Assets FY 2025 · Dec 31, 2025 $45.39M
Current Assets FY 2025 · Dec 31, 2024 $39.49M
Total Assets FY 2025 · Dec 31, 2025 $73.58M
Total Assets FY 2025 · Dec 31, 2024 $76.67M
Eps Diluted FY 2025 · Dec 31, 2025 −$4.85
Eps Diluted FY 2025 · Dec 31, 2024 −$88.13
Eps Basic FY 2025 · Dec 31, 2025 −$4.85
Eps Basic FY 2025 · Dec 31, 2024 −$88.13
Sga Expense FY 2025 · Dec 31, 2025 $35.15M
Sga Expense FY 2025 · Dec 31, 2024 $51.86M
Rd Expense FY 2025 · Dec 31, 2025 $11.37M
Rd Expense FY 2025 · Dec 31, 2024 $24.8M
Net Income FY 2025 · Dec 31, 2025 −$26.4M
Net Income FY 2025 · Dec 31, 2024 −$112.02M
Operating Income FY 2025 · Dec 31, 2025 −$33.34M
Operating Income FY 2025 · Dec 31, 2024 −$103.98M
Cost Of Revenue FY 2025 · Dec 31, 2025 $15.32M
Cost Of Revenue FY 2025 · Dec 31, 2024 $30.4M
Revenue FY 2025 · Dec 31, 2025 $28.51M
Revenue FY 2025 · Dec 31, 2024 $30.78M